Bioelectronics: Member Board of Directors @ Merck Group
Site Head, EMD Serono Research and Development Institute, Billerica, MA @ EMD Serono, Inc.
Global Head, Discovery and Development Technologies @ EMD Serono, Inc.
Member, Merck Ventures Investment Committee @ M Ventures
SVP, Global Head of Discovery and Development Technologies @ Merck Group
SVP, Head of Discovery and Development Technologies @ Merck Group
SVP, Global Head of Discovery Technologies @ Merck Group
VP, Global Head of Small Molecule Platform @ Merck Group
Senior Director, Global Head of Medicinal Chemistry @ Merck Group
Klaus Urbahns's Education
INSEAD
Business School: Executive Education
2020 - 2021
Stanford University
Graduate School of Business: Executive Education
2019 - 2020
Goethe University
Ph.D. (Organic Chemistry (Synthesis of macrolide antibiotic A26771B).)
1990 - 1993
The University of Freiburg
Diploma (Chemistry/Biochemistry (Synthesis of pseudo oligo-saccharides as alpha-amylase inhibitors).)
1986 - 1989
Kiel University
Vordiplom (Chemistry)
1984 - 1986
Klaus Urbahns's Skills
Chromatography
High Throughput Screening
Drug Design
Translational Medicine
Small Molecules
CRO
Synthetic Organic
Chemistry
HPLC
Pharmaceutical Research
Klaus Urbahns's Summary
Klaus Urbahns, based in Boston, MA, US, is currently a Chief Scientific Officer at ProFound Therapeutics, bringing experience from previous roles at Merck Group, EMD Serono, Inc. and M Ventures. Klaus Urbahns holds a 2020 - 2021 Business School: Executive Education @ INSEAD. With a robust skill set that includes Chromatography, High Throughput Screening, Drug Design, Translational Medicine, Small Molecules and more, Klaus Urbahns contributes valuable insights to the industry. Klaus Urbahns has 2 emails on RocketReach.